Hits: 959 img
In the silicone industry's procurement circles, "domestic or imported" is an eternal debate. Some are loyal advocates of imports—"cure stability is just better, I dare not switch." Some firmly back domestic—"half the price, nearly the same result." Others watch from the fence—"I'd like to switch to domestic, but I'm afraid of a crash."
In this article, we take no sides and shout no slogans. From the perspective of an industry engineer, we break the question apart: Does the gap between domestic and imported actually exist? In which links? Which gaps are real, and which are stereotypes? And under what circumstances can you switch with confidence, and when is it better to wait?
I. The Conclusion First: The Gap Exists, but Not Where You Think
Let me offer a judgment that may surprise many: the gap between domestic and imported is no longer in "activity."
When it comes to catalytic activity—that is, how fast and how thoroughly the silicone cures—the products of leading domestic manufacturers and the international big brands already stand basically on the same line. This is the genuine progress of the domestic industry over recent years: the fundamental chemistry is identical, the Karstedt structure is public knowledge, platinum raw material circulates globally—making a catalyst "work" is no longer an obstacle for domestic producers.
The real gap lies in three "hidden links" beyond activity: batch consistency, purity control, and the depth of technical service. These three are precisely the aspects ordinary users won't easily notice in short-term use, yet they determine the long-term experience.
II. Gap One: Batch Consistency
This is the most tangible gap between the domestic catalyst industry and the established foreign manufacturers.
What is batch consistency? It means the catalyst you buy this month cures identically to last month's batch, and to the batch from six months ago. It sounds like a basic requirement, but achieving it demands serious skill: every step of platinum complexation has subtle room for variation—raw material purity, reaction temperature, timing control, post-processing; a slight drift in any link, and the finished catalyst's activity quietly shifts.
Foreign giants have made the same product for decades, with process parameters polished over and over and quality-control systems tempered a thousand times—batch-to-batch performance is like "copy and paste." Domestic manufacturers generally started later and iterate fast; leading enterprises have greatly improved batch stability, but across the industry as a whole, situations where "some batches run a bit fast, some a bit slow" are still not uncommon.
What's the cost of batch fluctuation? Your curing process must repeatedly "chase the catalyst with adjustments": this batch's working time is just right, the next batch needs a tweak of the inhibitor; this batch's molding cycle is stable, the next inexplicably runs a few seconds long. Each batch's deviation seems minor on its own, but accumulated, it's continuous process noise. This is also the core reason many major plants' medical-grade and electronics-grade lines dare not casually switch suppliers—not distrust of domestic products' "ceiling," but wariness of domestic products' "floor fluctuation."
III. Gap Two: Ultimate Purity Control
The second gap lies in the limits of "cleanliness."
As we've stressed repeatedly, the high-end addition-cure silicone market—medical, food, optical—competes purely on purity: the fewer and the more controllable the impurities the catalyst brings in, the better the product's volatiles, haze, and biocompatibility. The barrier here isn't "whether impurities exist," but the molecular-level understanding and control of impurities: which impurities are present, at what levels, introduced from which process step, and removed layer by layer—behind this stands decades of accumulated analytical data and an extremely stringent quality-control philosophy.
In the documentation package of a major import supplier, even the identity and levels of trace impurities are spelled out clearly; some domestic products still fall short on transparency and control at this level. For ordinary industrial products, this difference is imperceptible; but for medical implant grade or optical grade, it's a wall you cannot bypass.
IV. Gap Three: The Depth of Technical Service
The third gap is the most easily underestimated: a catalyst isn't "done" once purchased—it's a raw material that needs to "run alongside you."
When developing a new formulation, how do you choose the catalyst, configure the inhibitor, tune the cure curve? When curing anomalies appear, is it the catalyst or the system? After changing process temperature, should the catalyst scheme move with it? The answers to these questions often live in the supplier engineers' experience base.
Foreign giants have cultivated the industry for decades and hold vast libraries of application cases and failure databases—they can tell you, "We've seen your problem at another customer; here's the cause." Sometimes that service is worth more than the product itself. Domestic manufacturers' technical service is improving rapidly—the application engineers at leading enterprises are no weaker than imported suppliers', and overall response speed is often faster (no language barriers, easy on-site visits)—but the industry-average "depth of experience" still lags.
V. So, Can You Switch to Domestic?
Having laid out the gaps, here's actionable switching advice.
Situations suited to trying domestic: ordinary industrial-grade products (molds, miscellaneous parts, general potting) with no extreme purity requirements; well-established incoming inspection capability (able to run cure-comparison tests); suppliers willing to provide samples and cooperate with trial-production validation. If all three are met, switching to domestic not only saves cost but may bring faster response and better service flexibility.
Situations calling for caution: medical, food, and optical fields extremely sensitive to purity—unless the supplier has thorough compliance documentation and accumulated batch data; production lines with narrow process windows and no margin for debugging; and that type of supplier who "can't produce batch data but insists everything performs identically"—be wary of the latter regardless of origin.
The correct way to switch: sample trial → small-batch trial production → three consecutive batches tracked → gradual changeover. Record cure comparisons for every batch, and let the data make the decision for you—not "domestic sentiment" or "import worship."
VI. Summary
The gap between domestic and imported is real, but it no longer lies
in activity—it lies in three hidden links: batch consistency, purity limits,
and technical-service depth. For ordinary applications, leading domestic
products are fully adequate options, with better value for money and service
response besides; for extreme high-end applications, imported products still
hold the edge in data accumulation and quality-control philosophy. The rational
attitude is not taking sides, but matching suppliers to product grade and
making switch decisions based on validated data—after all, what the silicone
industry has ever recognized is not pedigree, but the cure curve.
Special fluorosilicone rubber for turbocharger tube MY FHTV 4162 series